Abstract: The present invention relates to cross-linked and recyclable nanocompounds obtained by in situ terminal treatment of raw carbonaceous materials, including charcoal, tar, activated carbon, pyrolytic carbon, coke, graphite or others having conductive structures, including graphite, graphene, different carbon nanotubes, fullerenes or a combination thereof or their derivatives, and a polymer capable of dispersing and reversibly stabilising said components, having viscous or fluid behaviour below 200° C., and may have pendant groups acting as diene or dienophile, including furan-functionalised aliphatic polyketones, furan-functionalised polyesters, ethylene rubber with propylene functionalised with furan groups or a combination thereof.

Abstract: In one aspect, provided herein is a nanocarrier composition for formulating a hydrophilic and aromatic low molecular-weight drug (HALMD), the composition comprising: an aromatic polymer; and a hydrophilic and aromatic low molecular-weight drug (HALMD); wherein the aromatic polymer has a positive or negative charge or is a zwitterion, and the hydrophilic and aromatic low molecular-weight drug (HALMD) has an opposing positive or negative charge or is a zwitterion; and wherein the composition has a size of between 50-400 nm and optionally, a zeta potential of from +100 to ?100 mV. A method for preparing the nanocarrier composition, as well as pharmaceutical compositions and therapeutic uses thereof, are also disclosed.

Abstract: The present invention relates to a method for obtaining nanostructures, specifically nanoemulsions and nanocapsules of carotenoids such as curcumin and astaxanthin. This method—using particular concentrations of the ingredients forming the nanostructures—allows high association efficiencies of the active ingredient in the nanostructures containing these ingredients and protection of these nanostructures from environmental factors such as oxidation and light. The invention also relates to the nanoemulsions and nanocapsules of curcumin and astaxanthin for use in the food, pharmaceutical and cosmetics industries, among others.

Abstract: In one aspect, provided herein is a nanocarrier composition for formulating a hydrophilic and aromatic low molecular-weight drug (HALMD), the composition comprising: an aromatic polymer; and a hydrophilic and aromatic low molecular-weight drug (HALMD); wherein the aromatic polymer has a positive or negative charge or is a zwitterion, and the hydrophilic and aromatic low molecular-weight drug (HALMD) has an opposing positive or negative charge or is a zwitterion; and wherein the composition has a size of between 50-400 nm and optionally, a zeta potential of from +100 to ?100 mV. A method for preparing the nanocarrier composition, as well as pharmaceutical compositions and therapeutic uses thereof, are also disclosed.